Treatment of Tobacco Smoking | Lifestyle Behaviors | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Treatment of Tobacco SmokingA Review

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
Abstract

Importance  More deaths in the US are attributed to cigarette smoking each year than to any other preventable cause. Approximately 34 million people and an estimated 14% of adults in the US smoke cigarettes. If they stopped smoking, they could reduce their risk of tobacco-related morbidity and mortality and potentially gain up to 10 years of life.

Observations  Tobacco smoking is a chronic disorder maintained by physical nicotine dependence and learned behaviors. Approximately 70% of people who smoke cigarettes want to quit smoking. However, individuals who attempt to quit smoking make an average of approximately 6 quit attempts before achieving long-term abstinence. Both behavioral counseling and pharmacotherapy while using nicotine replacement therapy (NRT) products, varenicline, or bupropion are effective treatments when used individually, but they are most effective when combined. In a meta-analysis including 19 488 people who smoked cigarettes, the combination of medication and behavioral counseling was associated with a quit rate of 15.2% over 6 months compared with a quit rate of 8.6% with brief advice or usual care. The EAGLES trial, a randomized double-blind clinical trial of 8144 people who smoked, directly compared the efficacy and safety of varenicline, bupropion, nicotine patch, and placebo and found a significantly higher 6-month quit rate for varenicline (21.8%) than for bupropion (16.2%) and the nicotine patch (15.7%). Each therapy was more effective than placebo (9.4%). Combining a nicotine patch with other NRT products is more effective than use of a single NRT product. Combining drugs with different mechanisms of action, such as varenicline and NRT, has increased quit rates in some studies compared with use of a single product. Brief or intensive behavioral support can be delivered effectively in person or by telephone, text messages, or the internet. The combination of a clinician’s brief advice to quit and assistance to obtain tobacco cessation treatment is effective when routinely administered to tobacco users in virtually all health care settings.

Conclusions and Relevance  Approximately 34 million people in the US smoke cigarettes and could potentially gain up to a decade of life expectancy by stopping smoking. First-line therapy should include both pharmacotherapy and behavioral support, with varenicline or combination NRT as preferred initial interventions.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Nancy A. Rigotti, MD, Massachusetts General Hospital, 100 Cambridge St, Ste 1600, Boston, MA 02114 (rigotti.nancy@mgh.harvard.edu).

Accepted for Publication: January 12, 2021.

Conflict of Interest Disclosures: Dr Rigotti reported receiving grants from National Heart, Lung, and Blood Institute and Achieve Life Sciences and personal fees from UpToDate and Achieve Life Sciences. Dr Kruse reported having a family financial interest in Dimagi, Inc. Dr Hartmann-Boyce reported being the principal investigator on grants relevant to this work, for which funds were paid to the University of Oxford, from Cancer Research UK and the National Institute for Health Research (NIHR). No other disclosures were reported.

Funding/Support: Dr Livingstone-Banks is funded by the NIHR, via Cochrane Infrastructure funding to the Cochrane Tobacco Addiction Group.

Role of the Funder/Sponsor: The NIHR had no role in preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Disclaimer: The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR, National Health Service, or the Department of Health and Social Care.

References
1.
World Health Organization. Tobacco. Posted July 26, 2021. Accessed August 5, 2021. https://www.who.int/en/news-room/fact-sheets/detail/tobacco
2.
Cornelius  ME , Wang  TW , Jamal  A , Loretan  CG , Neff  LJ .  Tobacco product use among adults—United States, 2019.   MMWR Morb Mortal Wkly Rep. 2020;69(46):1736-1742. doi:10.15585/mmwr.mm6946a4 PubMedGoogle ScholarCrossref
3.
 The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. US Dept of Health and Human Services; 2014.
4.
Asfar  T , Perez  A , Shipman  P ,  et al.  National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999-2016).   Nicotine Tob Res. 2021;23(8):1308-1317. doi:10.1093/ntr/ntaa277 PubMedGoogle ScholarCrossref
5.
American Cancer Society.  Cancer Facts & Figures 2020. American Cancer Society; 2020.
6.
US Food and Drug Administration: Youth and tobacco. Accessed October 25, 2021. https://www.fda.gov/tobacco-products/public-health-education/youth-and-tobacco
7.
 Smoking Cessation: A Report of the Surgeon General—Executive Summary. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
8.
Jha  P , Ramasundarahettige  C , Landsman  V ,  et al.  21st-century hazards of smoking and benefits of cessation in the United States.   N Engl J Med. 2013;368(4):341-350. doi:10.1056/NEJMsa1211128 PubMedGoogle ScholarCrossref
9.
Benowitz  NL .  Nicotine addiction.   N Engl J Med. 2010;362(24):2295-2303. doi:10.1056/NEJMra0809890 PubMedGoogle ScholarCrossref
10.
Piper  ME .  Withdrawal: expanding a key addiction construct.   Nicotine Tob Res. 2015;17(12):1405-1415. doi:10.1093/ntr/ntv048 PubMedGoogle ScholarCrossref
11.
Chaiton  M , Diemert  L , Cohen  JE ,  et al.  Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers.   BMJ Open. 2016;6(6):e011045. doi:10.1136/bmjopen-2016-011045 PubMedGoogle Scholar
12.
Hughes  JR , Solomon  LJ , Naud  S , Fingar  JR , Helzer  JE , Callas  PW .  Natural history of attempts to stop smoking.   Nicotine Tob Res. 2014;16(9):1190-1198. doi:10.1093/ntr/ntu052 PubMedGoogle ScholarCrossref
13.
Creamer  MR , Wang  TW , Babb  S ,  et al.  Tobacco product use and cessation indicators among adults—United States, 2018.   MMWR Morb Mortal Wkly Rep. 2019;68(45):1013-1019. doi:10.15585/mmwr.mm6845a2 PubMedGoogle ScholarCrossref
14.
Babb  S , Malarcher  A , Schauer  G , Asman  K , Jamal  A .  Quitting smoking among adults—United States, 2000-2015.   MMWR Morb Mortal Wkly Rep. 2017;65(52):1457-1464. doi:10.15585/mmwr.mm6552a1 PubMedGoogle ScholarCrossref
15.
Heatherton  TF , Kozlowski  LT , Frecker  RC , Rickert  W , Robinson  J .  Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day.   Br J Addict. 1989;84(7):791-799. doi:10.1111/j.1360-0443.1989.tb03059.x PubMedGoogle ScholarCrossref
16.
Patnode  CD , Henderson  JT , Coppola  EL , Melnikow  J , Durbin  S , Thomas  RG .  Interventions for tobacco cessation in adults, including pregnant persons: updated evidence report and systematic review for the US Preventive Services Task Force.   JAMA. 2021;325(3):280-298. doi:10.1001/jama.2020.23541 PubMedGoogle ScholarCrossref
17.
Barua  RS , Rigotti  NA , Benowitz  NL ,  et al.  2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology task force on clinical expert consensus documents.   J Am Coll Cardiol. 2018;72(25):3332-3365. doi:10.1016/j.jacc.2018.10.027 PubMedGoogle ScholarCrossref
18.
Leone  FT , Zhang  Y , Evers-Casey  S ,  et al.  Initiating pharmacologic treatment in tobacco-dependent adults: an official American Thoracic Society clinical practice guideline.   Am J Respir Crit Care Med. 2020;202(2):e5-e31. doi:10.1164/rccm.202005-1982ST PubMedGoogle ScholarCrossref
19.
Hartmann-Boyce  J , Hong  B , Livingstone-Banks  J , Wheat  H , Fanshawe  TR .  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.   Cochrane Database Syst Rev. 2019;6:CD009670. doi:10.1002/14651858.CD009670.pub4 PubMedGoogle Scholar
20.
Stead  LF , Koilpillai  P , Fanshawe  TR , Lancaster  T .  Combined pharmacotherapy and behavioural interventions for smoking cessation.   Cochrane Database Syst Rev. 2016;3:CD008286. doi:10.1002/14651858.CD008286.pub3 PubMedGoogle Scholar
21.
Hartmann-Boyce  J , Chepkin  SC , Ye  W , Bullen  C , Lancaster  T .  Nicotine replacement therapy versus control for smoking cessation.   Cochrane Database Syst Rev. 2018;5:CD000146. doi:10.1002/14651858.CD000146.pub5 PubMedGoogle Scholar
22.
Cahill  K , Lindson-Hawley  N , Thomas  KH , Fanshawe  TR , Lancaster  T .  Nicotine receptor partial agonists for smoking cessation.   Cochrane Database Syst Rev. 2016;(5):CD006103. doi:10.1002/14651858.CD006103.pub7 PubMedGoogle Scholar
23.
Howes  S , Hartmann-Boyce  J , Livingstone-Banks  J , Hong  B , Lindson  N .  Antidepressants for smoking cessation.   Cochrane Database Syst Rev. 2020;4:CD000031.PubMedGoogle Scholar
24.
Lindson  N , Chepkin  SC , Ye  W , Fanshawe  TR , Bullen  C , Hartmann-Boyce  J .  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.   Cochrane Database Syst Rev. 2019;4:CD013308. doi:10.1002/14651858.CD013308 PubMedGoogle Scholar
25.
Chang  PH , Chiang  CH , Ho  WC , Wu  PZ , Tsai  JS , Guo  FR .  Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials.   BMC Public Health. 2015;15:689. doi:10.1186/s12889-015-2055-0 PubMedGoogle ScholarCrossref
26.
Hartmann-Boyce  J , McRobbie  H , Butler  AR ,  et al.  Electronic cigarettes for smoking cessation.   Cochrane Database Syst Rev. 2021;9:CD010216.PubMedGoogle Scholar
27.
Stead  LF , Buitrago  D , Preciado  N , Sanchez  G , Hartmann-Boyce  J , Lancaster  T .  Physician advice for smoking cessation.   Cochrane Database Syst Rev. 2013;(5):CD000165.PubMedGoogle Scholar
28.
Rice  VH , Heath  L , Livingstone-Banks  J , Hartmann-Boyce  J .  Nursing interventions for smoking cessation.   Cochrane Database Syst Rev. 2017;12:CD001188.PubMedGoogle Scholar
29.
Hartmann-Boyce  J , Livingstone-Banks  J , Ordóñez-Mena  JM ,  et al.  Behavioural interventions for smoking cessation: an overview and network meta-analysis.   Cochrane Database Syst Rev. 2021;1:CD013229.PubMedGoogle Scholar
30.
Livingstone-Banks  J , Ordóñez-Mena  JM , Hartmann-Boyce  J .  Print-based self-help interventions for smoking cessation.   Cochrane Database Syst Rev. 2019;1:CD001118.PubMedGoogle Scholar
31.
Matkin  W , Ordóñez-Mena  JM , Hartmann-Boyce  J .  Telephone counselling for smoking cessation.   Cochrane Database Syst Rev. 2019;5:CD002850.PubMedGoogle Scholar
32.
Tzelepis  F , Paul  CL , Williams  CM ,  et al.  Real-time video counselling for smoking cessation.   Cochrane Database Syst Rev. 2019;2019(10)CD012659.PubMedGoogle Scholar
33.
Stead  LF , Carroll  AJ , Lancaster  T .  Group behaviour therapy programmes for smoking cessation.   Cochrane Database Syst Rev. 2017;3:CD001007. doi:10.1002/14651858.CD001007.pub3 PubMedGoogle Scholar
34.
Lancaster  T , Stead  LF .  Individual behavioural counselling for smoking cessation.   Cochrane Database Syst Rev. 2017;3:CD001292.PubMedGoogle Scholar
35.
Lindson  N , Thompson  TP , Ferrey  A , Lambert  JD , Aveyard  P .  Motivational interviewing for smoking cessation.   Cochrane Database Syst Rev. 2019;7:CD006936.PubMedGoogle Scholar
36.
Whittaker  R , McRobbie  H , Bullen  C , Rodgers  A , Gu  Y , Dobson  R .  Mobile phone text messaging and app-based interventions for smoking cessation.   Cochrane Database Syst Rev. 2019;10:CD006611. doi:10.1002/14651858.CD006611.pub5 PubMedGoogle Scholar
37.
Taylor  GMJ , Dalili  MN , Semwal  M , Civljak  M , Sheikh  A , Car  J .  Internet-based interventions for smoking cessation.   Cochrane Database Syst Rev. 2017;9:CD007078.PubMedGoogle Scholar
38.
Notley  C , Gentry  S , Livingstone-Banks  J , Bauld  L , Perera  R , Hartmann-Boyce  J .  Incentives for smoking cessation.   Cochrane Database Syst Rev. 2019;7:CD004307.PubMedGoogle Scholar
39.
Fiore  MC , Jaen  CR , Baker  TB ,  et al; Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff.  A clinical practice guideline for treating tobacco use and dependence: 2008 update: a US Public Health Service report.   Am J Prev Med. 2008;35(2):158-176. doi:10.1016/j.amepre.2008.04.009 PubMedGoogle Scholar
40.
Anthenelli  RM , Benowitz  NL , West  R ,  et al.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.   Lancet. 2016;387(10037):2507-2520. doi:10.1016/S0140-6736(16)30272-0 PubMedGoogle ScholarCrossref
41.
Mills  EJ , Wu  P , Lockhart  I , Wilson  K , Ebbert  JO .  Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.   Tob Induc Dis. 2010;8:8. doi:10.1186/1617-9625-8-8 PubMedGoogle ScholarCrossref
42.
Baker  TB , Piper  ME , Stein  JH ,  et al.  Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial.   JAMA. 2016;315(4):371-379. doi:10.1001/jama.2015.19284 PubMedGoogle ScholarCrossref
43.
Evins  AE , Benowitz  NL , West  R ,  et al.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES trial.   J Clin Psychopharmacol. 2019;39(2):108-116. doi:10.1097/JCP.0000000000001015 PubMedGoogle ScholarCrossref
44.
Thomas  KD , Dalili  MN , López-López  J ,  et al.  Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomised controlled trials.   Addiction. Published online October 11, 2021. doi:10.1111/add.15675 PubMedGoogle Scholar
45.
Hajek  P , Smith  KM , Dhanji  AR , McRobbie  H .  Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? a randomised controlled trial.   BMC Med. 2013;11:140. doi:10.1186/1741-7015-11-140 PubMedGoogle ScholarCrossref
46.
Koegelenberg  CFN , Noor  F , Bateman  ED ,  et al.  Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.   JAMA. 2014;312(2):155-161. doi:10.1001/jama.2014.7195 PubMedGoogle ScholarCrossref
47.
Ramon  JM , Morchon  S , Baena  A , Masuet-Aumatell  C .  Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation.   BMC Med. 2014;12:172. doi:10.1186/s12916-014-0172-8 PubMedGoogle ScholarCrossref
48.
Ebbert  JO , Hatsukami  DK , Croghan  IT ,  et al.  Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.   JAMA. 2014;311(2):155-163. doi:10.1001/jama.2013.283185 PubMedGoogle ScholarCrossref
49.
Ebbert  JO , Hughes  JR , West  RJ ,  et al.  Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.   JAMA. 2015;313(7):687-694. doi:10.1001/jama.2015.280 PubMedGoogle ScholarCrossref
50.
Lindson  N , Klemperer  E , Hong  B , Ordóñez-Mena  JM , Aveyard  P .  Smoking reduction interventions for smoking cessation.   Cochrane Database Syst Rev. 2019;9:CD013183.PubMedGoogle Scholar
51.
Lindson-Hawley  N , Hartmann-Boyce  J , Fanshawe  TR , Begh  R , Farley  A , Lancaster  T .  Interventions to reduce harm from continued tobacco use.   Cochrane Database Syst Rev. 2016;10(10):CD005231. doi:10.1002/14651858.CD005231.pub3 PubMedGoogle Scholar
52.
Walker  N , Howe  C , Glover  M ,  et al.  Cytisine versus nicotine for smoking cessation.   N Engl J Med. 2014;371(25):2353-2362. doi:10.1056/NEJMoa1407764 PubMedGoogle ScholarCrossref
53.
West  R , Zatonski  W , Cedzynska  M ,  et al.  Placebo-controlled trial of cytisine for smoking cessation.   N Engl J Med. 2011;365(13):1193-1200. doi:10.1056/NEJMoa1102035 PubMedGoogle ScholarCrossref
54.
Courtney  RJ , McRobbie  H , Tutka  P ,  et al.  Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial.   JAMA. 2021;326(1):56-64. doi:10.1001/jama.2021.7621 PubMedGoogle ScholarCrossref
55.
Walker  N , Smith  B , Barnes  J ,  et al.  Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial.   Addiction. 2021;116(10):2847-2858. doi:10.1111/add.15489 PubMedGoogle ScholarCrossref
56.
National Academies of Sciences, Engineering, and Medicine.  Public Health Consequences of E-Cigarettes. National Academies Press; 2018.
57.
Fiore  MC , Schroeder  SA , Baker  TB .  Smoke, the chief killer—strategies for targeting combustible tobacco use.   N Engl J Med. 2014;370(4):297-299. doi:10.1056/NEJMp1314942 PubMedGoogle ScholarCrossref
58.
Royal College of Physicians.  Nicotine Without Smoke: Tobacco Harm Reduction. Royal College of Physicians; 2016.
59.
McNeill  A , Brose  L , Calder  R , Simonavicius  E , Robson  D .  Vaping in England: An Evidence Update Including Vaping for Smoking Cessation, February 2021: A Report Commissioned by Public Health England. Public Health England; 2021.
60.
Baker  TB , McCarthy  DE .  Smoking treatment: a report card on progress and challenges.   Annu Rev Clin Psychol. 2021;17:1-30. doi:10.1146/annurev-clinpsy-081219-090343 PubMedGoogle ScholarCrossref
61.
Sheffer  CE , Payne  T , Ostroff  JS ,  et al.  Increasing the quality and availability of evidence-based treatment for tobacco dependence through unified certification of tobacco treatment specialists.   J Smok Cessat. 2016;11(4):229-235. doi:10.1017/jsc.2014.30 Google ScholarCrossref
62.
Clancy  CM , Kirsh  S .  Virtual care and the pandemic: are we reaching all patients?   Ann Intern Med. 2021;174(1):116-117. doi:10.7326/M20-5593 PubMedGoogle ScholarCrossref
63.
Kotsen  C , Dilip  D , Carter-Harris  L ,  et al.  Rapid scaling up of telehealth treatment for tobacco-dependent cancer patients during the COVID-19 outbreak in New York City.   Telemed J E Health. 2021;27(1):20-29. doi:10.1089/tmj.2020.0194 PubMedGoogle ScholarCrossref
64.
Byaruhanga  J , Paul  CL , Wiggers  J ,  et al.  The short-term effectiveness of real-time video counselling on smoking cessation among residents in rural and remote areas: an interim analysis of a randomised trial.   J Subst Abuse Treat. 2021;131:108448. doi:10.1016/j.jsat.2021.108448 PubMedGoogle Scholar
65.
Byaruhanga  J , Wiggers  J , Paul  CL ,  et al.  Acceptability of real-time video counselling compared to other behavioural interventions for smoking cessation in rural and remote areas.   Drug Alcohol Depend. 2020;217:108296. doi:10.1016/j.drugalcdep.2020.108296 PubMedGoogle Scholar
66.
Barnes  J , McRobbie  H , Dong  CY , Walker  N , Hartmann-Boyce  J .  Hypnotherapy for smoking cessation.   Cochrane Database Syst Rev. 2019;6:CD001008.PubMedGoogle Scholar
67.
White  AR , Rampes  H , Liu  JP , Stead  LF , Campbell  J .  Acupuncture and related interventions for smoking cessation.   Cochrane Database Syst Rev. 2014;(1):CD000009. doi:10.1002/14651858.CD000009.pub4 PubMedGoogle Scholar
68.
Krist  AH , Davidson  KW , Mangione  CM ,  et al; US Preventive Services Task Force.  Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force Recommendation Statement.   JAMA. 2021;325(3):265-279. doi:10.1001/jama.2020.25019 PubMedGoogle Scholar
69.
VanFrank  B , Presley-Cantrell  L .  A comprehensive approach to increase adult tobacco cessation.   JAMA. 2021;325(3):232-233. doi:10.1001/jama.2020.23608 PubMedGoogle ScholarCrossref
71.
Sherman  SE , Takahashi  N , Kalra  P ,  et al.  Care coordination to increase referrals to smoking cessation telephone counseling: a demonstration project.   Am J Manag Care. 2008;14(3):141-148.PubMedGoogle Scholar
72.
Vidrine  JI , Shete  S , Cao  Y ,  et al.  Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings.   JAMA Intern Med. 2013;173(6):458-464. doi:10.1001/jamainternmed.2013.3751 PubMedGoogle ScholarCrossref
73.
Tindle  HA , Daigh  R , Reddy  VK ,  et al; Pennsylvania eReferral Workgroup.  eReferral between hospitals and quitlines: an emerging tobacco control strategy.   Am J Prev Med. 2016;51(4):522-526. doi:10.1016/j.amepre.2016.05.024 PubMedGoogle ScholarCrossref
74.
Patients not ready to make a quit attempt now (the “5 R's”). Agency for Healthcare Research and Quality. Last reviewed December 2012. Accessed August 16, 2021. https://www.ahrq.gov/prevention/guidelines/tobacco/5rs.html
75.
Cigarette labeling and health warning requirements. US Food and Drug Administration. Reviewed August 25, 2021. Accessed January 7, 2022. https://www.fda.gov/tobacco-products/labeling-and-warning-statements-tobacco-products/cigarette-labeling-and-health-warning-requirements#a
76.
FDA commits to evidence-based actions aimed at saving lives and preventing future generations of smokers. US Food and Drug Administration. Posted April 29, 2021. Accessed January 7, 2022. https://www.fda.gov/news-events/press-announcements/fda-commits-evidence-based-actions-aimed-saving-lives-and-preventing-future-generations-smokers
77.
Kalkhoran  S , Benowitz  NL , Rigotti  NA .  Prevention and treatment of tobacco use: JACC health promotion series.   J Am Coll Cardiol. 2018;72(9):1030-1045. doi:10.1016/j.jacc.2018.06.036 PubMedGoogle ScholarCrossref
78.
Nash  SH , Liao  LM , Harris  TB , Freedman  ND .  Cigarette smoking and mortality in adults aged 70 years and older: results from the NIH-AARP cohort.   Am J Prev Med. 2017;52(3):276-283. doi:10.1016/j.amepre.2016.09.036 PubMedGoogle ScholarCrossref
79.
Rigotti  NA , McDermott  MM .  Smoking cessation and cardiovascular disease: it’s never too early or too late for action.   J Am Coll Cardiol. 2019;74(4):508-511. doi:10.1016/j.jacc.2019.06.003 PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close